2019
Friday Fri
Pediatric Grand Rounds (CME) - Pediatric Tuberculosis
Kristen Wendorf, MD, MS - California Department of Public Health
Highlighting the work public health does in identifying and treating people with TB disease and their contacts so that the medical system and the public health system can work in concert to help eliminate TB from California.
Session Description:
There have been many recent updates to the diagnosis and treatment of latent TB (LTBI) in children including a focus on targeted TB testing, increasing use of interferon-gamma release assays (IGRAs), and multiple new shorted treatment regimens for LTBI treatment. It is important that both specialists who care for children who receive immunosuppressive medications as well as general pediatric providers are aware of these changes. In brief, only children at elevated risk of TB progression or exposure should undergo TB testing. IGRAs are the preferred TB test for children aged 2 years and older who were born outside of the US. Isoniazid is no longer a preferred treatment regimen for LTBI; this is replaced by a weekly dose of isoniazid and rifapentine for 12 weeks or a daily dose of rifampin for 4 months. It's also important to highlight the work public health does in identifying and treating people with TB disease and their contacts so that the medical system and the public health system can work in concert to help eliminate TB from California.
Education goals for this session:
- Identify children in need of TB testing
- Assess when to use an interferon-gamma release assay to help diagnose latent TB disease
- Use shortest effective treatment regimen for latent TB disease
- Recognize public health's role in identifying, treating, and preventing TB disease in children
Location
725 Welch Road
Palo Alto, CA 94304
USA
LPCH Auditorium, West
725 Welch RoadPalo Alto, CA 94304
Speaker
Kristen Wendorf, MD, MS
Public Health Medical Officer
Chief, Program Development Section, Tuberculosis Control Branch
Division of Communicable Disease Control, Center for Infectious Diseases
California Department of Public Health
CME Credit
Accreditation
The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
The Stanford University School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Cultural and Linguistic Competency
California Assembly Bill 1195 requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area. The Stanford University School of Medicine Multicultural Health Portal also contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws. You are encouraged to visit the portal: http://lane.stanford.edu/portals/cultural.html